Who has invested in Talkiatry?

Andreessen Horowitz are named among the investors backing Talkiatry.

Talkiatry Funding: $130M Raised, Series C (2024)

Talkiatry funding overview

Talkiatry has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in June 2024. The round record for Talkiatry runs through 2024; nothing later has been disclosed. Investors on record include Andreessen Horowitz.

Talkiatry at a glance

Total raised: $130M
Latest round: Series C
Latest round date: June 2024
Notable investors: Andreessen Horowitz

Frequently asked about Talkiatry funding

How much has Talkiatry raised?: Talkiatry has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Talkiatry?: Andreessen Horowitz are named among the investors backing Talkiatry.
What was the latest Talkiatry funding round?: The most recent disclosed round is a Series C, announced in June 2024.
Where is Talkiatry based?: No headquarters location is disclosed for Talkiatry.
When did Talkiatry last raise?: The last disclosed Talkiatry round closed in June 2024 at Series C.

Talkiatry totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Talkiatry Funding: $130M Raised, Series C (2024)

Talkiatry funding overview

Talkiatry at a glance

Frequently asked about Talkiatry funding

Companies related to Talkiatry (18)

Browse related funding lists (4)